SDC1 and Miyoshi myopathy: Because of the heterogeneity among CD138+ enriched cells in MM (Fig. 2a–e), we followed two complementary strategies: (1) Where the cell numbers allowed it, across the (discovery) cohort we performed proteotyping analysis of plasma cells enriched by their CD138 surface expression using MACS for 77 patient samples (Supplementary Table 3).